EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy

Maxime Ferrand, Céline J Rocca, Guillaume Corre, Valentina Buffa, Sophie Frin, Francine Garnache-Ottou, Elodie Bôle-Richard, Sonia Albini, Isabelle Richard, Anne Galy

Molecular Therapy Methods & Clinical Development · 2025-09 · 33 (3) · 101545

DOI: 10.1016/j.omtm.2025.101545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Methods & Clinical Development, 2025-09. Verfasst von Maxime Ferrand und 9 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris-Saclay, Univ Evry, Inserm, Integrare Research Unit UMR_S951, Genethon, 91000 Evry-Courcouronnes, France. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: INSERM, Institut Pasteur, Infrastructures en Biologie Santé et Agronomie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue fibrosis is a pathological feature of many diseases including muscular dystrophies such as Duchenne muscular dystrophy (DMD). Fibrosis may limit the effectiveness of gene therapy in muscle impacting on viral dosing but direct evidence is lacking. Strategies to reduce skeletal muscle fibrosis are limited. The fibrosis Fap gene is over-expressed in the skeletal muscles of a severe mouse model of DMD, suggesting that cells expressing membrane fibroblast activation protein (FAP) could be targeted by chimeric antigen receptor (CAR)-T cells. Two consecutive administrations of FAP-specific CAR-T cells in the severe DMD model reduced collagen deposits and fibrotic biomarkers and also reduced the number of FAP-positive cells in muscle. Single cell transcriptomics revealed that FAP-CAR-T cells triggered cellular interactions with otherwise inactive muscle resident macrophages and depleted specific subsets of FAP-highly-expressing fibro-adipogenic progenitor cells, pointing to their importance in the fibrosis process. Reducing fibrosis with FAP-CAR-T cells enhanced adeno-associated virus (AAV) microdystrophin gene transfer in the model by increasing vector copies, demonstrating that fibrosis is a restriction factor for AAV gene delivery in skeletal muscle. These results provide novel insights into therapeutic strategies for DMD or other fibrotic diseases.

Schlagwörter

Stichwörter der Autor:innen

AAVCAR-T cellsFAP proteinfibro-adipogenic progenitor cellsfibrosisimmunotherapymuscular dystrophyscRNA-seq

Autor:innen und Institutionen

  • Université Paris-Saclay, Univ Evry, Inserm, Integrare Research Unit UMR_S951, Genethon, 91000 Evry-Courcouronnes, France.
  • Genethon, 91000 Evry-Courcouronnes, France.
  • Université Marie et Louis Pasteur, EFS, Inserm, UMR1098 RIGHT, 25000 Besançon, France.
  • FC'innov, Bionoveo, 25000 Besançon, France.

Förderung

  • INSERM
  • Institut Pasteur
  • Infrastructures en Biologie Santé et Agronomie

Zitieren

APA

Ferrand, M., Rocca, C. J., Corre, G., Buffa, V., Frin, S., Garnache-Ottou, F., Bôle-Richard, E., Albini, S., Richard, I., & Galy, A. (2025). FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy. Molecular Therapy Methods & Clinical Development, 33(3), 101545. https://doi.org/10.1016/j.omtm.2025.101545

Vancouver

Ferrand M, Rocca CJ, Corre G, Buffa V, Frin S, Garnache-Ottou F, et al. FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy. Molecular Therapy Methods & Clinical Development. 2025;33(3):101545. doi:10.1016/j.omtm.2025.101545

BibTeX
@article{Ferrand2025,
  author = {Ferrand, Maxime and Rocca, Céline J and Corre, Guillaume and Buffa, Valentina and Frin, Sophie and Garnache-Ottou, Francine and Bôle-Richard, Elodie and Albini, Sonia and Richard, Isabelle and Galy, Anne},
  title = {FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy},
  journal = {Molecular Therapy Methods & Clinical Development},
  year = {2025},
  volume = {33},
  number = {3},
  pages = {101545},
  doi = {10.1016/j.omtm.2025.101545}
}
Kostenlos starten →